ATE526012T1 - Pharmazeutische formulierungen von meloxicam - Google Patents
Pharmazeutische formulierungen von meloxicamInfo
- Publication number
- ATE526012T1 ATE526012T1 AT09176632T AT09176632T ATE526012T1 AT E526012 T1 ATE526012 T1 AT E526012T1 AT 09176632 T AT09176632 T AT 09176632T AT 09176632 T AT09176632 T AT 09176632T AT E526012 T1 ATE526012 T1 AT E526012T1
- Authority
- AT
- Austria
- Prior art keywords
- meloxicam
- pharmaceutical formulations
- meglumin
- dimethylacetamide
- oral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2008/09200A TR200809200A1 (tr) | 2008-12-01 | 2008-12-01 | Meloksikam içeren farmasötik formülasyonlar |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE526012T1 true ATE526012T1 (de) | 2011-10-15 |
Family
ID=40847870
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT09176632T ATE526012T1 (de) | 2008-12-01 | 2009-11-20 | Pharmazeutische formulierungen von meloxicam |
Country Status (5)
Country | Link |
---|---|
US (1) | US20100137292A1 (de) |
EP (1) | EP2191820B1 (de) |
AT (1) | ATE526012T1 (de) |
ES (1) | ES2374626T3 (de) |
TR (1) | TR200809200A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100297252A1 (en) * | 2003-03-03 | 2010-11-25 | Elan Pharma International Ltd. | Nanoparticulate meloxicam formulations |
US8512727B2 (en) * | 2003-03-03 | 2013-08-20 | Alkermes Pharma Ireland Limited | Nanoparticulate meloxicam formulations |
ES2609415T3 (es) * | 2009-05-27 | 2017-04-20 | Alkermes Pharma Ireland Limited | Reducción de agregación laminar en composiciones con nanopartículas de meloxicam |
JOP20200109A1 (ar) * | 2012-04-23 | 2017-06-16 | Otsuka Pharma Co Ltd | مستحضر قابل للحقن |
EP2703728B2 (de) † | 2012-09-03 | 2023-11-08 | BSH Hausgeräte GmbH | Kochfeldvorrichtung |
KR20210007951A (ko) | 2018-05-11 | 2021-01-20 | 난징 델로바 바이오테크 컴퍼니 리미티드 | 멜록시캄 조성물, 제제 및 이의 제조 방법 및 응용 |
CN115068419A (zh) * | 2022-07-22 | 2022-09-20 | 潍坊恒邦兽药有限公司 | 兽用高浓度美洛昔康注射剂及其加工设备 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2756113A1 (de) | 1977-12-16 | 1979-06-21 | Thomae Gmbh Dr K | Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel |
WO1999009988A1 (en) * | 1997-08-27 | 1999-03-04 | Hexal Ag | New pharmaceutical compositions of meloxicam with improved solubility and bioavailability |
EP0945134A1 (de) | 1998-03-27 | 1999-09-29 | Boehringer Ingelheim Pharma KG | Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation |
WO2001037838A1 (fr) * | 1999-11-24 | 2001-05-31 | Wakamoto Pharmaceutical Co., Ltd. | Preparation aqueuse ophtalmique |
DE10030345A1 (de) | 2000-06-20 | 2002-01-10 | Boehringer Ingelheim Vetmed | Hochkonzentrierte stabile Meloxicamlösungen |
US20020035107A1 (en) * | 2000-06-20 | 2002-03-21 | Stefan Henke | Highly concentrated stable meloxicam solutions |
DE10161077A1 (de) | 2001-12-12 | 2003-06-18 | Boehringer Ingelheim Vetmed | Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion |
DE10250081A1 (de) * | 2002-10-25 | 2004-05-13 | Boehringer Ingelheim Vetmedica Gmbh | Wasserlösliche Meloxicam Granulate |
US8992980B2 (en) * | 2002-10-25 | 2015-03-31 | Boehringer Ingelheim Vetmedica Gmbh | Water-soluble meloxicam granules |
EP1972340A3 (de) * | 2003-07-10 | 2008-11-26 | Arturo Jimenez Bayardo | Verfahren für die Zubereitung einer wässrigen Meloxicam-Lösung und auf diese Weise hergestellte wässrige Lösung |
DE102004021281A1 (de) | 2004-04-29 | 2005-11-24 | Boehringer Ingelheim Vetmedica Gmbh | Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin |
DE102004030409A1 (de) | 2004-06-23 | 2006-01-26 | Boehringer Ingelheim Vetmedica Gmbh | Neue Verwendung von Meloxicam in der Veterinärmedizin |
US20070281927A1 (en) * | 2006-06-06 | 2007-12-06 | Shanthakumar Tyavanagimatt | Anti-inflammatory and analgesic compositions and related methods |
EP2293777B1 (de) | 2008-06-24 | 2015-02-25 | Intervet International B.V. | Transdermale pharmazeutische zusammensetzung und verfahren zur behandlung von entzündungen bei rindern |
-
2008
- 2008-12-01 TR TR2008/09200A patent/TR200809200A1/xx unknown
-
2009
- 2009-11-20 AT AT09176632T patent/ATE526012T1/de not_active IP Right Cessation
- 2009-11-20 EP EP09176632A patent/EP2191820B1/de active Active
- 2009-11-20 ES ES09176632T patent/ES2374626T3/es active Active
- 2009-11-30 US US12/591,753 patent/US20100137292A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2191820A1 (de) | 2010-06-02 |
ES2374626T3 (es) | 2012-02-20 |
US20100137292A1 (en) | 2010-06-03 |
EP2191820B1 (de) | 2011-09-28 |
TR200809200A1 (tr) | 2009-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE526012T1 (de) | Pharmazeutische formulierungen von meloxicam | |
EA200700653A1 (ru) | Система контролируемой доставки | |
CY1120564T1 (el) | Υδατικα εναιωρηματα tmc278 | |
CY1124690T1 (el) | Σκευασματα ενδοφλεβιου διαλυματος ποσακοναζολης σταθεροποιημενα με υποκατεστημενη βητα-κυκλοδεξτρινη | |
MD4577C1 (ro) | Compoziţii masticabile de uz veterinar care conţin agent activ izoxazolinic şi utilizarea acestora în tratamentul sau prevenirea unei infestări sau infecţii parazitare | |
CY1118057T1 (el) | Φαρμακευτικη συνθεση για στοματικη χορηγηση | |
CL2008003595A1 (es) | Compuestos heterociclicos nitrogenados, antagonistas del receptor de taquiquinina; agente farmaceutico que comprende el compuesto; y uso en la profilaxis o el tratamiento de una enfermedad del tracto urinario inferior, una enfermedad gastrointestinal o una enfermedad del sistema nervioso central. | |
CY1114363T1 (el) | Ανθελμινθικος συνδυασμος | |
EA200800360A1 (ru) | Формуляции с высоким содержанием лекарства и дозированные формы | |
UY29108A1 (es) | Ligandos de difenil éter terapéuticos | |
AR069211A1 (es) | Derivados de acidos de 1,2,4-oxadiazol ciclobutanoamino carboxilicos, una composicion farmaceutica, proceso de preparacion del compuesto y su uso para preparar medicamentos | |
SV2011003907A (es) | Composiciones antimicrobianas | |
RS53201B (en) | BENDAMUSTIN ORAL DOSAGE FORMS | |
CY1111442T1 (el) | Ενωσεις πιπεριδινης και χρησεις αυτων | |
EP4356968A3 (de) | Langzeitwirkende formulierungen | |
PL2229938T3 (pl) | Kompozycje ezetymibu | |
ATE364402T1 (de) | Stabile injizierbare diclofenac- zubereitungen | |
MA32964B1 (fr) | Formulation a effet retard d'octreotide avec niveau d'exposition constamment eleves | |
CL2022000875A1 (es) | Inhibidores del factor d del complemento para administración oral | |
EA201291104A1 (ru) | Пероральные лекарственные формы бендамустина | |
CY1112227T1 (el) | Πιπεριδινυλαμινο-πυριδαζινες και η χρηση τους ως ταχεως διασπομενοι ανταγωνιστες υποδοχεα ντοπαμινης 2 | |
NO20083183L (no) | Fast farmasoytisk sammensetning inneholdende irbesartan | |
CY1119777T1 (el) | Φαρμακευτικη συνθεση περιλαμβανουσα (1r,4r)-6'-φθοpo-n,n-διμεθυλ-4-φαινυλ-4',9'διυδρο-3'h-σπειρο[κυκλοεξανο-1,1'-πυρανο[3,4,β]ινδολ]-4-αμινη και γκαμπαπεντινοειδες | |
RU2007136310A (ru) | Способ получения наноразмерной системы доставки лекарственных средств на основе диоксида кремния | |
CO6630124A2 (es) | Terapia de combinación que comprende un antagonista de ccr5, un inhibidor de proteasa de vih-1, y un potenciador farmacocinético |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |